Business of Biotech- Trends in Life Science Funding & Exits|Tim Shannon,General Partner,Canaan Partners 00:10:00
Tim pairs his operating experience and medical background to create value for companies from the earliest stage through FDA approval. Prior to becoming an investor, Tim began as a pulmonary and critical care physician, and was the president and chief executive officer of CuraGen, a publicly traded biopharmaceutical company focused on oncology. Tim earned his medical degree from the University of Connecticut and has a B.A. in chemistry from Amherst College.
